H19 and endometrial cancer: Our previous genome-scale methylation studies from human endometrial cancer cells revealed a correlation between decreased H19 expression and increased methylation at multiple CpG sites within a highly conserved promoter region of human Hnf4α (Figure 4a) (Supplementary Data S1 in ref. 16).